EODData

SHE, 301281: Shandong Keyuan Pharmaceutical Co. Ltd. A

10 Apr 2026
LAST:

34.79

CHANGE:
 0.67
OPEN:
34.37
HIGH:
35.20
ASK:
0.00
VOLUME:
3.91M
CHG(%):
1.96
PREV:
34.12
LOW:
33.64
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Apr 2634.3735.2033.6434.793.91M
09 Apr 2634.3735.8133.7034.124.71M
08 Apr 2635.7336.7735.3035.813.84M
07 Apr 2634.3735.4333.9635.154.17M
03 Apr 2635.6736.1233.8534.063.76M
02 Apr 2636.9737.0035.5135.903.1M
01 Apr 2636.0037.5735.0037.214.84M
31 Mar 2637.1837.4935.4035.523.99M
30 Mar 2638.1838.7636.1237.506.63M
27 Mar 2640.0040.8037.8339.208.08M

PROFILE

Name:Shandong Keyuan Pharmaceutical Co. Ltd. A
About:Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of active pharmaceutical ingredients. It offers gliclazide, for the treatment of NIDDM; metformin hydrochloride used as an adjunct to diet and exercise in adult patients with NIDDM; isosorbide mononitrate for prevention of angina pectoris and treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction; isosorbide dinitrate to prevent angina pectoris due to coronary artery disease; mecobalamin for peripheral neuropathies; lansoprazole to treat acid-reflux disorders, peptic ulcer disease, h. pylori eradication, and prevention of gastrointestinal bleeds; ropivacaine hydrochloride for obstetric and regional anesthesia; isoflurane; fluoxetine hydrochloride, an anti-depression drug; clemastine fumarate, an anti-allergic agent; isoprenaline hydrochloride to treat mild or transient episodes of heart block; esmolol hydrochloride for the rapid control of ventricular rate; xanthinol nicotinate to treat of brain function barrier, cerebral embolism and cerebral thrombosis; amlexanox for treatment of aphthous ulcers; nisolsipine for hypertension; clarithromycin lactobionate; trepibutone; propafenone hydrochloride; diclofenac potassium to treat osteoarthritis and rheumatoid arthritis; chlorzoxazone for relief of discomfort associated with acute painful musculoskeletal conditions; esomeprazole sodium treats related gastric ulcer disease and zollinger-ehrlich syndrome; palonosetron hydrochloride, a chemotherapy adjuvant medication; edaravone, a cerebral protective agent; vildagliptin to treat diabetes; etamsylate, a hemostatic medication; pranoprofen that is a non-steroidal anti-inflammatory analgesic and antipyretic drugs; parecoxib sodium; and lurasidone hydrochloride, a medication for schizophrenia. The company was incorporated in 2004 and is headquartered in Jinan, China.
Sector:Healthcare
Address:Keyuan Street, Jinan, China, 251601
Website:https://www.keyuanpharm.com
ISIN:CNE1000061V8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:61.77 
Price to Sales:7.37 
Price to Book:2.34 
Profit Margin:0.12 
Operating Margin:-0.07 
Return on Assets:0.01 
Return on Equity:0.04 
DivYield:0.01 
Div/Share:0.20 
Revenue:435.52M 
EBITDA:85.57M 
Shares:108.29M 
Market Cap:3.767B 

TECHNICAL INDICATORS

MA5:34.790.0%
MA10:35.933.3%
MA20:41.6619.7%
MA50:39.4113.3%
MA100:34.351.3%
MA200:34.201.7%
STO9:15.53 
STO14:5.17 
RSI14:24.16 
WPR14:-94.09 
MTM14:-9.11
ROC14:-0.21 
ATR:2.79 
Week High:36.775.7%
Week Low:33.643.4%
Month High:53.9955.2%
Month Low:33.641.7%
Year High:53.9955.2%
Year Low:25.8734.5%
Volatility:46.70 

RECENT SPLITS

Date Ratio
26 May 20231-1

RECENT DIVIDENDS

Date Amount
20 May 2025$0.20
30 Apr 2024$0.30